Stay up-to-date with the most recent news stories from around the world
AbbVie has entered an agreement to acquire Apogee Therapeutics for $10.9 billion to bolster its immunology portfolio. The deal focuses on zumilokibart, a next-generation treatment for inflammatory diseases that offers significantly less frequent dosing than current market leaders.
Jack Ma and the collective leadership of Alibaba and Ant Group held a symbolic rice-planting retreat in Hangzhou to emphasize long-term strategic patience. The event served to demonstrate executive unity and debunk rumors of talent flight, specifically regarding Chief Scientist Zhou Jingren.
China's Type 076 amphibious assault ship is nearing flight trials, with analysis suggesting it can operate the J-35 stealth fighter thanks to its electromagnetic catapults. While hangar space and deck bottlenecks pose challenges, the vessel positions China to deploy 'mini-carrier' capabilities that could outperform Western equivalents in specific maritime scenarios.
CCTV's unprecedented release of DF-17 hypersonic missile footage marks a strategic shift in Chinese military transparency. The display signals an evolution in China's nuclear doctrine as it moves from passive minimum deterrence toward a more flexible and technologically advanced retaliatory posture.
Newly discovered archival documents provide primary evidence of the Imperial Japanese Army injecting animal blood into human subjects during World War II. These findings add to the historical record of war crimes committed in occupied China and continue to influence the strained diplomatic relations between Beijing and Tokyo.
Iranian negotiators have concluded high-stakes talks in Switzerland focused on a memorandum of understanding that links a ceasefire in Lebanon to the unfreezing of Iranian assets and oil exports. The agreement establishes a monitoring mechanism involving Qatar and Pakistan to ensure both the U.S. and Iran meet specific technical and military benchmarks.
The Iranian negotiation team has announced a five-point agreement with the United States, signaling a major breakthrough in bilateral relations. This framework is expected to address nuclear constraints and sanctions relief, potentially reshaping the security architecture of the Middle East.
United States and Iranian negotiators have established a five-point framework in Switzerland to de-escalate tensions, featuring temporary oil sanctions relief and a maritime hotline. The agreement includes Iran in Lebanon's ceasefire monitoring and utilizes Qatar to manage the release of frozen assets, marking a significant shift toward regional pragmatism.
The Chinese aircraft carrier Liaoning and its strike group have reportedly engaged in multiple tense encounters with Japanese forces during recent Western Pacific deployments. These incidents highlight the growing frequency of tactical friction as China seeks to normalize its naval presence beyond the First Island Chain.
The Liaoning carrier strike group has completed a major training cycle in the South China Sea and Western Pacific, marking a significant milestone in China's maritime power projection. These exercises emphasize the People’s Liberation Army Navy’s transition toward sophisticated, far-sea combat operations and its ability to operate beyond the first island chain.
Recent military drills by the PLA Rocket Force featuring the DF-17 hypersonic missile signal a shift toward 'systemic suppression' of Taiwan's defenses. While Taiwan focuses on tactical emergency readiness, the widening gap in industrial capacity and technological integration suggests a growing asymmetry in cross-strait military power.
China's fiscal data from early 2026 highlights a significant shift as stock trading tax revenue nearly doubled while land-related revenue plummeted by nearly 30 percent. This divergence underscores the ongoing struggle to pivot from a real estate-driven growth model toward a more diversified, capital-market-oriented economy.
Chinese agricultural giant Beidahuang must pay 1.41 billion yuan in back taxes and fees after a decade of improper incentive claims. The tax hit comes as the company faces an eight-year decline in profit margins and systemic compliance issues within its insurance subsidiary.
Premier Li Qiang will attend the 17th Summer Davos in Dalian to deliver a keynote address and engage with global business leaders. The forum aims to showcase China's economic openness and innovation potential to a delegation of 1,700 representatives from over 90 nations.
Chinese authorities have launched a high-level, inter-agency investigation into the presence of the toxic chemical formamide in baby diapers. The probe highlights a critical gap in national safety standards and reflects the government's urgent effort to manage a growing consumer trust crisis involving major domestic and international brands.
Former Federal Reserve Chairman Alan Greenspan has passed away at age 100, leaving behind a complex legacy as the architect of the 'Great Moderation' and a lightning rod for criticism regarding the 2008 financial crisis.
Huawei's automotive subsidiary, Yinwang, will increase the price of its 'Qiankun' ADS Max smart-driving package from 32,000 to 36,000 RMB on July 1, 2026. The price hike is accompanied by enhanced service protections for urban and highway navigation features, signaling a shift toward higher-margin software monetization in the smart car sector.
International joint-venture automakers are withdrawing flagship internal combustion models from Chinese showrooms as ICE sales collapse by nearly 40%. With NEV penetration hitting record highs and massive discounts failing to move inventory, the traditional dealership model is facing a terminal crisis.
Honor has launched the X80 Pro Max in China, featuring a massive 11,000mAh battery and a 10,000nits display for 1,999 RMB. The device represents a strategic pivot toward extreme hardware specifications and durability in the competitive mid-range smartphone market.
Hansoh Pharma's Olapepeptide has moved toward commercialization in China with an accepted NDA and strong Phase III data showing 19.3% weight loss. The drug distinguishes itself through a unique biased-signaling mechanism that significantly reduces the gastrointestinal side effects common in other GLP-1 treatments.
